Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104451 · ClinicalTrials.gov registry record · Phase 1
Phase 1, Open-label Safety Study OF Umbilical Cord Lining Mesenchymal Stem Cells (corlicyte®) TO Heal Chronic Diabetic Foot Ulcers
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT04104451 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 16 participants.
The verdict
NCT04104451, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Study Objective: The objective of this Phase 1 open-label study is to establish the safety and tolerability of Corlicyte mesenchymal stem cells (MSCs) in the treatment of patients with chronic diabetic foot ulcers (DFUs).
Interventions
- DRUG Corlicyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2023-08-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04104451
The ClinicalTrials.gov registry entry for NCT04104451 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corlicyte is the first listed.
NCT04104451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04104451 about?
NCT04104451 is a clinical study titled "Phase 1, Open-label Safety Study OF Umbilical Cord Lining Mesenchymal Stem Cells (corlicyte®) TO Heal Chronic Diabetic Foot Ulcers". Study Objective: The objective of this Phase 1 open-label study is to establish the safety and tolerability of Corlicyte mesenchymal stem cells (MSCs) in the treatment of patients with chronic diabetic foot ulcers (DFUs).
What is the current status of trial NCT04104451?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2019-11-12. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT04104451?
The interventions under investigation include: Corlicyte (DRUG).
Who is sponsoring clinical trial NCT04104451?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.